Dr. Dima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 2018 - 2021
University of AthensClass of 2017
Certifications & Licensure
OH State Medical License 2021 - 2025
WA State Medical License 2024 - 2025
MA State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel
Blood Cancer Journal. 2024-12-05 - Safety and efficacy of B cell maturation antigen-directed CAR T-cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis.Utkarsh Goel, Danai Dima, James Davis, Nausheen Ahmed, Hira Shaikh
European Journal of Haematology. 2024-12-01 - Clonal hematopoiesis in large granular lymphocytic leukemia.Naomi Kawashima, Carmelo Gurnari, Carlos Bravo-Perez, Yasuo Kubota, Simona Pagliuca
Leukemia. 2024-11-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
